Clinical Trial Update: A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of escalating doses of basimglurant in healthy volunteers and patients with major depres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Basimglurant (basimglurant)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Major Depressive Disorder, Healthy Volunteer | Phase 1 | Status: COMPLETED